| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | -0.07 | 0.03 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.03 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.067 | 0.03 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.067 | 0.03 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.03 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.33 | 0.04 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.04 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.04 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.04 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.04 |